Table 2:
Correlation of Adverse Events (AEs) With Demographic, Procedural, and Post-treatment Variables
| Variable | Adverse events | No adverse events | P value |
|---|---|---|---|
| Demographic | |||
| Age (med, IQR) | 63.5 (6.6) | 63.0 (12.0) | 0.2961 |
| Gender (n [%]) | |||
| Female | 19 (7.2) | 245 (92.8) | 0.8127 |
| Male | 1 (9.1) | 10 (90.9) | |
| Skin type (n) | |||
| I | 6 | 49 | |
| II | 9 | 130 | 0.6787 |
| III | 4 | 66 | |
| IV | 1 | 10 | |
| Procedural | |||
| Number of passes | |||
| Median (range) | |||
| Perioral | 3 (2-3) | 3 (2-4) | 0.4650 |
| Periorbital | 3 (2-3) | 3 (2-3) | 0.3824 |
| Forehead | 3 (3-3) | 3 (2-3) | 0.4550 |
| Nose | 3 (3-3) | 3 (2-3) | 0.4784 |
| Cheeks | 3 (2-3) | 3 (2-3) | 0.8089 |
| Mandibular border | 2 (2-3) | 2 (1-3) | 0.8672 |
| Posttreatment (n) | 0.8695 | ||
| Cicalfate | 0 | 1 | |
| Silicone | 1 | 19 | |
| Silicone-Cicalfate | 7 | 109 | |
| Stratamed | 0 | 4 | |
| Stratamed-Cicalfate | 8 | 84 | |
| Xeroform | 0 | 1 | |
| Xeroform-Stratamed-Cicalfate | 0 | 5 | |
| Xeroform-Stratamed-Cicalfate | 2 | 10 |
Results of statistical analysis attempting to identify any correlations with AEs. n = number of patients. IQR = interquartile range, the difference between the 75th and 25th percentile, a measure of dispersion. Range = maximum minus minimum. Of note, no statistically significant correlation between any AE and any demographic, procedure or post-treatment variables was identified.